Eli Lilly and Company
Among the top 10 pharmaceutical companies in the world, Eli Lilly & Company has partnered with IUSM on multiple initiatives. Within the PH initiative, they are particularly excited to partner with us on genomic medicine and precision health cohort, as well as engaging in chemical biology programs.
The latest company developed by the parent company Cook Holdings, Cook Regentec is dedicated to commercializing cell and gene therapies. They are assisting with the cGMP facility and will be our partner to commercialize any therapies we develop in the Cell, Gene & Immune Therapy cluster.
Regenstrief Institute is an affiliated organization with IUSM and the repository of international known medical informatics programs. It houses the Indiana Network Patient Care (INPC), unparalleled source deep electronic health records for most Indiana natives. We have a long history of partnering with them to conduct numerous informatics projects.
Deloitte is an international corporation that specializes in many different types of technologies, including informatics, computational tool commercialization and most recently in genomic sciences. They will partner with IUSM and Regenstrief in order to help develop the informatics tools necessary for precision health and if successful, commercialize them for us.